Clinical trials Enasitenib outperforms conventional care in pretreated older IDH2-mutant R/R AML patients Read more
Clinical trials Lisocabtagene maraleucel meets its primary endpoint of complete response rate in R/R CLL and S... Read more
Clinical trials Impressive response with immuno- plus chemotherapy in patients with Hodgkin’s lymphoma Read more
Clinical trials No survival benefit from adding gilteritinib to azacitidine in newly-diagnosed FLT3-mutated pa... Read more
Clinical trials Ivosidenib plus azacitidine for patients with IDH1-mutated acute myeloid leukaemia Read more
Clinical trials Encouraging results with loncastuximab tesirine plus rituximab for DLBCL patients Read more
Clinical trials Triple combination of obinutuzumab, acalabrutinib and venetoclax not (yet) recommended in pati... Read more
Clinical trials Lenalidomide plus rituximab is an efficient chemo-free alternative for patients with advanced ... Read more
